Cardiology

Prepared apixaban (Eliquis) for launch in its first indication (VTE prevention in Orthopaedic surgery) - liaising with haematologists, orthopaedic surgeons and preparing for the launch in Atrial Fibrillation (AF), it's second indication.
Congress activity, promotional & patient material templates and reference material (for implementation across Western & Eastern Europe, Canada, Australia and New Zealand). Leading the branding, promotional and messaging workstream and the stakeholder workstream - the latter including the responsibility to lead advisory panels and round tables (agenda, selecting faculty, producing content, slides, slide rehearsals, materials etc). (Pfizer).

Updated materials in angina for ranolazine (Menarini), working closely with medical, regulatory and the sales team in producing clinical folder summaries, patient support materials, working with key opinion leaders at the Royal Brompton, Hammersmith & Charing Cross hospitals.

As a medical representative (at Hoechst AG), sold the 5th to market ACE inhibitor, Tritace, to cardiologists and other relevant clinicians and healthcare providers, working with marketing of the UK to implement activities including meetings. In addition, a loop diuretic (Lasoride) indicated for hypertension and pentoxifylline (Trental) in vascular conditions.